Celyad Oncology SA Operating Cycle 2011-2026 | CYAD

Annual Operating Cycle Celyad Oncology SA

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	64.4	131 K	-	-	-	-

All numbers in EUR currency

Maximum	Minimum	Average
131 K	64.4	65.4 K

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Amgen AMGN	282	$ 350.13	2.98 %	$ 188 B	USA
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
Amneal Pharmaceuticals AMRX	117	$ 12.73	3.33 %	$ 3.99 B	USA
Autolus Therapeutics plc AUTL	129	$ 1.48	8.82 %	$ 394 M	Britain
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
Arcutis Biotherapeutics ARQT	291	$ 24.57	5.59 %	$ 3.13 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	360	$ 2.68	4.28 %	$ 16.8 M	USA
Avid Bioservices CDMO	148	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
Cerus Corporation CERS	47	$ 1.93	4.62 %	$ 368 M	USA
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
CTI BioPharma Corp. CTIC	90.1	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Cyclacel Pharmaceuticals CYCCP	185	-	-4.36 %	$ 27 M	USA
Deciphera Pharmaceuticals DCPH	2.1 K	-	-	$ 2.18 B	USA
Dynavax Technologies Corporation DVAX	512	-	-	$ 2.02 B	USA
Coherus BioSciences CHRS	656	$ 1.73	3.59 %	$ 203 M	USA